SCHEMBL14973243

SCHEMBL14973243

CON(C)C(=O)c1cnn(C)c1COc1ccc(C(F)(F)F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
MAOB P27338 2/20 0.41
GRM4 Q14833 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PTPN1 P18031 1/20 0.38
PPARD Q03181 3/20 0.38
PPARA Q07869 1/20 0.38
FLT3 P36888 1/20 0.38
SLC6A5 Q9Y345 3/20 0.38
MLYCD O95822 1/20 0.38
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
HTR2B P41595 1/20 0.37
MCHR1 Q99705 1/20 0.37
PPARG P37231 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
KDM4C Q9H3R0 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973189 0.88 MAOB (0.42) BCHEACHEMAOBGRM4ALDH1A1
SCHEMBL14972951 0.84 MAOB (0.52) MAOBGRM4ALDH1A1PTPN1PPARD
SCHEMBL14972954 0.84 KDM4C (0.47) MAOBGRM4ALDH1A1PTPN1PPARD
SCHEMBL14973018 0.82 MAOB (0.44) MAOBGRM4ALDH1A1PTPN1PPARD
SCHEMBL14972953 0.81 ALDH1A1 (0.52) MAOBGRM4ALDH1A1PPARDPPARA
SCHEMBL14972952 0.80 MAPT (0.52) MAOBALDH1A1PPARDPPARG
SCHEMBL14973190 0.80 SLC6A5 (0.43) MAOBGRM4ALDH1A1PPARDPPARA
Hydrochloric Acid SCHEMBL14973129 0.79 SLC6A5 (0.42) MAOBGRM4ALDH1A1PPARDPPARA
SCHEMBL14973157 0.77 RXRA (0.42) MAOBALDH1A1FLT3SLC6A5ADRA1D
SCHEMBL14973102 0.76 HMOX1 (0.38) MAOBGRM4ALDH1A1FLT3SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A BCHE 1271/4885ACHE 399/4885MAOB 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.